Risk Factors for Diabetes Mellitus Patients Against Covid-19

Jasmin Ananda Wulan, Afrita Amalia Laitupa, Kartika Prahasanti

Abstract

ABSTRACT

Covid-19 patients with Diabetes mellitus (DM) ranked third after hypertension and cardiovascular disease with an estimated 36% of all Covid-19 cases. These patients have a risk of experiencing a higher complication possibility since their metabolic disorder can cause hyperglycemia to the patient. It is showed that the number of deaths reached 7,3%, which is higher than non-diabetes. The increase of DM patients caused by stress factors may trigger the onset of glucose in blood sugar, and the glucose variability became abnormal. This circumstance may cause a glycemic increase that causes the predisposition intensification of susceptible affected by Covid-19. Good management is truly needed for DM patients affected by Covid-19. It is hoped to reduce the risk factor, such as preventing complications and increasing life quality by regular medical check to have a good prognosis. Some research showed that Covid-19 patients with DM are essential in ICU and need more treatment attention as they may experience Acute Respiratory Distress Syndrome (ARDS). Diabetes mellitus patients' treatment strategy is to manage the blood glucose level, especially in post-prandial glucose. This literature aims to know the degree of serious illness of Covid-19 patients by the comorbidity of DM in this pandemic event.

 

Keywords: Covid-19, Sars-Cov-2, Diabetes Mellitus, risk factors,

Correspondence: jasminananda@gmail.com

Keywords

Risk factors, Diabetes Mellitus, Covid-19

Full Text:

PDF

References

Akhtar Hussain, Bishwajit Bhowmik, NC do VM (2020) 'Since January 2020 Elsevier has created a COVID-19 resource center with free information in English and Mandarin on the coronavirus novel COVID-19. The COVID-19 resource center is hosted on Elsevier Connect, the company 's public news and information', (January).

Chen, G. et al. (2020) 'Blood glucose levels in elderly subjects with type 2 diabetes during COVID-19 outbreak:a retrospective study in a single center 1. Center of Health Management, Fujian Provincial Hospital South Branch, Shengli Clinical Medical College of Fujian Medica '.

Christos, Sowers, JR e. A. and M (2020) 'Commentary: COVID-19 in Patients with Diabetes', Metabolism. Elsevier Inc., 107, p. 154217. doi: 10.1016 / j.metabol.2020.154217.

van Doremalen, N. et al. (2020) 'Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1', The New England Journal of Medicine, 2019 (March). doi: 10.1056 / NEJMc2004973.

Fatimah, RN (2015) 'DIABETES MELITUS TYPE 2', 4, pp. 93–101.

Goldenberg, R. and Punthakee, Z. (2013) 'Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome', Canadian Journal of Diabetes, 37 (SUPPL.1), pp. 8–11. doi: 10.1016 / j.jcjd.2013.01.011.

Guo, YR et al. (2020) 'The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - update on the status', Military Medical Research. Military Medical Research, 7 (1), pp. 1–10. doi: 10.1186 / s40779-020-00240-0.

Gupta, R. et al. (2020) 'Clinical considerations for patients with diabetes in the times of COVID-19 epidemic', Diabetes and Metabolic Syndrome: Clinical Research and Reviews. Indian Diabetes, 14 (3), pp. 211-212. doi: 10.1016 / j.dsx.2020.03.002.

Hestiana, DW (2017) 'Factors Associated with Compliance in Diet Management in Type 2 Diabetes Mellitus Outpatients in Semarang City', Journal of Health Education, 2 (2), pp. 137–145. doi: 10.15294 / jhe.v2i2.14448.

Van Der Hoek, L. et al. (2016) 'Identification of a new human coronavirus', Nature Medicine, 10 (4), pp. 368–373. doi: 10.1038 / nm1024.

Hoffman, T. et al. (2020) 'Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2 ', Infection Ecology and Epidemiology. Taylor & Francis, 10 (1). doi: 10.1080 / 20008686.2020.1754538.

Huang, I., Lim, MA and Pranata, R. (2020) 'Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression: Diabetes and COVID -19 ', Diabetes and Metabolic Syndrome: Clinical Research and Reviews. Elsevier Ltd, 14 (4), pp. 395–403. doi: 10.1016 / j.dsx.2020.04.018.

Hussain, A., Bhowmik, B. and do Vale Moreira, NC (2020) 'COVID-19 and diabetes: Knowledge in progress', Diabetes Research and Clinical Practice. The Author (s), 162, p. 108142. doi: 10.1016 / j.diabres.2020.108142.

Jia, W. et al. (2019) 'Standards of medical care for type 2 diabetes in China 2019', Diabetes / Metabolism Research and Reviews, 35 (6), pp. 1–26. doi: 10.1002 / dmrr.3158.

Katulanda, P. et al. (2020) 'Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature', Diabetology. Diabetology. doi: 10.1007 / s00125-020-05164-x.

KeAi (2020) 'Since January 2020 Elsevier has created a COVID-19 resource center with free information in English and Mandarin on the COVID-19 coronavirus novel. The COVID-19 resource center is hosted on Elsevier Connect, the company 's public news and information', (January).

Kelly, J. (2016) 'Diabetes: What is diabetes?', CDC National Center for Chronic Disease Prevention and Health Promotion, pp. 1–3.

Lodise, TP and Rybak, MJ (2020) 'COVID-19: Important Therapy Considerations and Approaches in this Hour of Need.', Pharmacotherapy, pp. 0–3. doi: 10.1002 / phar.2396.

Long, C. et al. (2020) 'Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?', European Journal of Radiology. Elsevier Ireland Ltd, 126, p. 108961. doi: 10.1016 / j.ejrad.2020.108961.

Lu, J. et al. (2020) 'Care for diabetes with COVID-19: Advice from China', Journal of Diabetes, (March), pp. 417–419. doi: 10.1111 / 1753-0407.13036.

Mardani, R. et al. (2020) 'Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study. ', Archives of academic emergency medicine, 8 (1), p. e43. Available at: http://www.ncbi.nlm.nih.gov/pubmed/32259132.

Misra, A. (2020) 'Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations', Diabetes and Metabolic Syndrome: Clinical Research and Reviews. Indian Diabetes, 14 (4), pp. 303-310. doi: 10.1016 / j.dsx.2020.04.004.

Morawska, L. and Cao, J. (2020) 'Airborne transmission of SARS-CoV-2: The world should face the reality', Environment International. Elsevier, 139 (April), p. 105730. doi: 10.1016 / j.envint.2020.105730.

Muniyappa, R. and Gubbi, S. (2020) 'COVID-19 pandemic, coronaviruses, and diabetes mellitus', pp. 736-741. doi: 10.1152 / ajpendo.00124.2020.

Rahmadi, A. (2019) Diabetes Mellitus.

Ramanathan, K. et al. (2020) 'Since January 2020 Elsevier has created a COVID-19 resource center with free information in English and Mandarin on the COVID coronavirus novel - research that is available on the COVID-19 resource center - including this for unrestricted research re-use a ', (January), pp. 19–21.

Rothan, HA and Byvydy, SN (2020) 'The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak', Journal of Autoimmunity. Elsevier, 109 (March), p. 102433. doi: 10.1016 / j.jaut.2020.102433.

Rubino, F. et al. (2020) 'Practical recommendations for management of diabetes in patients with COVID-19', The Lancet Diabetes and Endocrinology. Elsevier Ltd, 8587 (20), pp. 1–5. doi: 10.1016 / S2213-8587 (20) 30152-2.

Shereen, MA et al. (2020) 'COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses', Journal of Advanced Research. THE AUTHORS, 24, pp. 91–98. doi: 10.1016 / j.jare.2020.03.005.

Shi, H. et al. (2020) 'Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study', The Lancet Infectious Diseases. Elsevier Ltd, 20 (4), pp. 425–434. doi: 10.1016 / S1473-3099 (20) 30086-4.

Singh, AK et al. (2020) 'Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations', Diabetes and Metabolic Syndrome: Clinical Research and Reviews. Indian Diabetes, 14 (4), pp. 303-310. doi: 10.1016 / j.dsx.2020.04.004.

Soelistijo, S. et al. (2015) Consensus on the Management and Prevention of Type 2 Diabetes Mellitus in Indonesia 2015, Perkeni. Available at: https://www.google.com/url?sa=t&source=web&rct=j&url=https://pbperkeni.or.id/wp-content/uploads/2019/01/4.-Consensus-Management- and-Prevention of Diabetes-mellitus-type-2-in-Indonesia-PERKENI-2015.pdf & ved = 2ahUKEwjy8KOs8cfoAhXCb30KHQb1Ck0QFjADegQIBhAB & ultrasound = AOv.

Tinku, J. (2020) 'International pulmonologist's consensus on'.

Tjandrawinata, RR (2016) 'Pathogenesis of Type 2 Diabetes: Resistance to Insulin Deficiency', Dexa Medica Group, (February), pp. 1–4.

Vandeleene, B. and Yombi, J. (2020) 'charges', Annales d'Endocrinologie. Elsevier Masson SAS, pp. 1–9. doi: 10.1016 / j.ando.2020.05.001.

Wanxia, M. and Xingwu, R. (2020) 'The treatment of new coronavirus pneumonia must pay attention to blood sugar management *', 51 (2017), pp. 146–150.

Weina et al. (2020) 'Diabetes is a risk factor for the progression and prognosis of COVID-19', Diabetes / Metabolism Research and Reviews, (March), pp. 1–9. doi: 10.1002 / dmrr.3319.

WHO (2020a) 'Novel Coronavirus Disease (COVID-19): Situation Update Report-8', World Health Organization, pp. 1–6.

WHO (2020b) 'Suggestions for the use of immunodiagnostic tests at health facilities (point of care) for COVID-19', (April), pp. 8–11.

Wu, C. et al. (2020) 'Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China', JAMA Internal Medicine, pp. 1–10. doi: 10.1001 / jamainternmed.2020.0994.

Zhang, J. jin et al. (2020) 'Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China', Allergy: European Journal of Allergy and Clinical Immunology, (February), pp. 1–12. doi: 10.1111 / all.14238.

Zhou, F. et al. (2020) 'Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study', The Lancet. Elsevier Ltd, 6736 (20), pp. 1–9. doi: 10.1016 / S0140-6736 (20) 30566-3.

Zhou, J. and Tan, J. (2020) 'Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China', Metabolism: Clinical and Experimental. Elsevier Inc., 107, p. 154216. doi: 10.1016 / j.metabol.2020.154216.


DOI: http://dx.doi.org/10.30651/jqm.v5i2.4999